Morbidity Management and Disability Prevention for Blinding Trachoma and Lymphatic Filariasis

Post Date

July 8th 2013

Application Due Date

August 5th 2013

Funding Opportunity Number

SOL-OAA-13-000107

CFDA Number(s)

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

To be eligible for the Cooperative Agreement under this RFA, an organization must: a)Be a U.S. or non-U.S. based non-governmental institution, for-profit, non-profit or private voluntary organization, or consortium of such organizations; b)Have the managerial, technical, and institutional capacities to achieve the results outlined in this RFA; c)The prime recipient or lead organization in the consortium must have a long standing and demonstrated history of providing quality surgical services and the complimenting technical assistance for trachoma.); and, d)Have the capacity to collaborate with other organizations/groups to mobilize resources and disseminate best practices. USAID welcomes applications from organizations which have not previously done business with USAID.

Funding

• Estimated Total Funding:

  $35000000

• Award Range:

  $None - $35000000

Grant Description

More than 1 billion people worldwide suffer from a group of painful and debilitating diseases collectively referred to as neglected tropical diseases (NTDs). These diseases disproportionately impact poor, rural, and marginalized populations, and contribute to compromised mental and physical development, childhood malnutrition, reduced school enrollment and performance, and diminished economic productivity. The United States Agency for International Development (USAID) focuses on control and elimination of seven NTDs that can be targeted with preventive chemotherapy, including: lymphatic filariasis (LF), blinding trachoma, onchocerciasis, schistosomiasis and three soil-transmitted helminthiases (STH). In addition to causing sickness, several of these diseases can also lead to severe and lifelong morbidity and disability. To address morbidity and disability caused by blinding trachoma and LF, USAID through its NTD Program seeks to award a five-year, $35 million Cooperative Agreement to support countries to increase access to morbidity management and disability prevention (MMDP) services for blinding trachoma and LF. This activity will provide USAID, the Bureau for Global Health (GH), and the NTD Program with assistance to strengthen MMDP components within national NTD plans and achieve elimination goals for blinding trachoma in countries already supported by USAIDуs NTD Program. This activity will assist countries in planning, implementing, and monitoring the scale-up of high-quality treatment and care services for affected individuals.

Contact Information

• Agency

  Agency for International Development

• Office:

  None

• Agency Contact:

  Saurabh Vasudeva
  Agreement Specialist
  Phone 2025274195

• Agency Mailing Address:

  svasudeva@usaid.gov

• Agency Email Address:

  svasudeva@usaid.gov